Teva Pharmaceutical Industries Limited Earnings Dividend

Teva Pharmaceutical Industries Limited’s revenue fell -0.81% since last year same period to $4142Mn in the Q2 2026. On a quarterly growth basis, Teva Pharmaceutical Industries Limited has generated 4.04% jump in its revenue since last 3-months.

Teva Pharmaceutical Industries Limited’s net profit fell -304.26% since last year same period to $-576Mn in the Q2 2026. On a quarterly growth basis, Teva Pharmaceutical Industries Limited has generated -256.1% fall in its net profits since last 3-months.

Teva Pharmaceutical Industries Limited’s net profit margin fell -305.93% since last year same period to -13.91% in the Q2 2026. On a quarterly growth basis, Teva Pharmaceutical Industries Limited has generated -250.03% fall in its net profit margins since last 3-months.

Teva Pharmaceutical Industries Limited’s earning per share (EPS) estimates for the current quarter stand at 0.71 - a 1320% jump from last quarter’s estimates.

Teva Pharmaceutical Industries Limited’s earning per share (EPS) estimates for the current year stand at 0.71.

Teva Pharmaceutical Industries Limited’s earning per share (EPS) fell -3.03% since last year same period to 0.64 in the Q2 2026. This indicates that the Teva Pharmaceutical Industries Limited has generated -3.03% annual rate of fall in its earning per share (EPS) in the last 4 quarters.